本文言語 | English |
---|---|
ページ(範囲) | 6388-6389 |
ページ数 | 2 |
ジャーナル | Annals of Surgical Oncology |
巻 | 28 |
号 | 11 |
DOI | |
出版ステータス | Published - 2021 10月 |
ASJC Scopus subject areas
- 外科
- 腫瘍学
UN SDG
この成果は、次の持続可能な開発目標に貢献しています
文献へのアクセス
他のファイルとリンク
引用スタイル
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Annals of Surgical Oncology, Vol. 28, No. 11, 10.2021, p. 6388-6389.
研究成果: Article › 査読
}
TY - JOUR
T1 - ASO Author Reflections
T2 - The Impact of Early Skeletal Muscle Loss Within 1 Week After Esophagectomy on Long-term Prognosis in Patients with Esophageal Cancer
AU - Matsui, Kazuaki
AU - Kawakubo, Hirofumi
AU - Hirata, Yuki
AU - Matsuda, Satoru
AU - Mayanagi, Shuhei
AU - Irino, Tomoyuki
AU - Fukuda, Kazumasa
AU - Nakamura, Rieko
AU - Wada, Norihito
AU - Kitagawa, Yuko
N1 - Funding Information: Kazumasa Fukuda—I belong to the Keio University School of Medicine Endowed Chair in Cancer Research (funded by Chugai Pharmaceutical Co., Ltd and Taiho Pharmaceutical Co., Ltd). Yuko Kitagawa—Relevant financial activities outside the submitted work: Chugai Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd, Yakult Honsha Co. Ltd. Asahi Kasei Pharma Corporation, Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Tsumura & Co., Kyouwa Hakkou Kirin Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Ea Pharma Co., Ltd., Astellas Pharma Inc., Toyama Chemical Co., Ltd., Medicon Inc., Kaken Pharmaceutical Co. Ltd., Eisai Co., Ltd., Otsuka Pharmaceutical Factory Inc., Teijin Pharma Limited., Nihon Pharmaceutical Co., Ltd., Nippon Covidien Inc., Shionogi & Co., Ltd.
PY - 2021/10
Y1 - 2021/10
UR - http://www.scopus.com/inward/record.url?scp=85101780031&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85101780031&partnerID=8YFLogxK
U2 - 10.1245/s10434-021-09670-z
DO - 10.1245/s10434-021-09670-z
M3 - Article
C2 - 33638046
AN - SCOPUS:85101780031
SN - 1068-9265
VL - 28
SP - 6388
EP - 6389
JO - Annals of Surgical Oncology
JF - Annals of Surgical Oncology
IS - 11
ER -